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Abstract
Background: The objective was to explore the usefulness of the morbidity risk adjustment system
Adjusted Clinical Groups® (ACG), in comparison with age and gender, in explaining and estimating
patient costs on an individual level in Swedish primary health care. Data were retrieved from two
primary health care centres in southeastern Sweden.
Methods: A cross-sectional observational study. Data from electronic patient registers from the
two centres were retrieved for 2001 and 2002, and patients were grouped into ACGs, expressing
the individual combination of diagnoses and thus the comorbidity. Costs per patient were
calculated for both years in both centres. Cost data from one centre were used to create ACG
weights. These weights were then applied to patients at the other centre. Correlations between
individual patient costs, age, gender and ACG weights were studied. Multiple linear regression
analyses were performed in order to explain and estimate patient costs.
Results: The variation in individual patient costs was substantial within age groups as well as within
ACG weight groups. About 37.7% of the individual patient costs could be explained by ACG
weights, and age and gender added about 0.8%. The individual patient costs in 2001 estimated 22.0%
of patient costs in 2002, whereas ACG weights estimated 14.3%.
Conclusion: ACGs was an important factor in explaining and estimating individual patient costs in
primary health care. Costs were explained to only a minor extent by age and gender. However,
the usefulness of the ACG system appears to be sensitive to the accuracy of classification and
coding of diagnoses by physicians.
Background
Accurate methods are needed for estimating the burden of
morbidity in a population to enable resource allocation
corresponding to the health care needs of the population.
This is particularly important in relation to the funding of
primary health care (PHC) centres, as there is greater var-
iation in terms of need between localities than between
regions or counties [1]. Determinants of health care utili-
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sation and health care costs are of great interest in this
context, and a number of factors have been identified in
empirical investigations [2]. In a study from Canada, age
and gender explained only 5–9% of the variation in
health care expenditures [3]. The influence of morbidity
and of socio-economic factors has also been investigated.
The studies showed that there was substantial variation in
hospital admission rates among general practitioners
(GPs) due to socio-demographic patient factors associated
with deprivation [4,5].
In countries with a national health care system, where
public authorities are responsible for health care provi-
sion in regions and smaller areas, interest has focused on
demographic and socio-economic determinants of health
care needs. In this regard, the underprivileged area score
(UPA), or the Jarman index, was developed in the UK [6].
The index has been adapted to Swedish conditions,
slightly modified, and renamed the Care Need Index
(CNI) [7].
In countries with a health care system primarily based on
individual health insurance, interest has focused on meas-
ures based on individual patients' characteristics. In the
USA, several instruments have been developed to com-
pensate for differences in case-mix and to adjust for differ-
ences in risk [3]. One of these instruments is the Adjusted
Clinical Groups® (ACG) system, which assigns patients to
morbidity categories based on disease patterns and
expected resource requirements [8,9]. The grouping algo-
rithm enables each diagnosis to be classified as one out of
32 types of morbidity (Aggregated Diagnosis Groups),
depending on five combined criteria: i) likely persistence
of the condition, ii) grade of severity, iii) aetiology, iv)
diagnostic certainty, and v) need for speciality care. Thus
each ACG is used as an estimate for a group of patients
with the same constellation of morbidities, thereby indi-
cating the need for care of each category of patients.
Research, development and documentation of the ACG
system has been performed mainly in the USA [8-12] and
Canada [3,13-15], and only a few European studies of the
ACG system have been published [16-19].
The ability of the ACG system to measure individual
comorbidity and the burden of morbidity in a population
is of special interest from a PHC perspective, since a GP
cares for a number of individual patients who often suffer
from several diseases, all of which are normally treated by
the GP. A retrospective study was conducted on encounter
data from a three-year period in a Swedish county council
and it is published in this issue of BMC Public Health.
The aim of this study is to explore the usefulness of the
ACG system, in comparison with age and gender, in
explaining and estimating patient costs on an individual
level in a Swedish PHC setting.
Methods
Setting
Two PHC centres in the county of Östergötland in south-
eastern Sweden were included in the study. Ödeshög PHC
centre is situated in a rural municipality with about 5600
inhabitants. Ryd PHC centre has a registered patient pop-
ulation of about 9000 and is located in the city of
Linköping, with about 130 000 inhabitants. The two PHC
centres will be referred to as Ödeshög and Ryd. Both are
complete Swedish PHC centres with GPs, district nurses,
physiotherapists, occupational therapists and social work-
ers. Both use electronic patient record (EPR) systems –
BMS® in Ödeshög, and Swedestar® in Ryd. The Swedish
PHC version of the International Classification of Dis-
eases and Related Health Problems (ICD-10) was used for
labelling health problems [20]. Ödeshög was involved in
this study to create ACG weights, and Ryd was used to
explore the usefulness of the ACG system.
Data retrieval
Data from the EPRs of all patients at both PHC centres for
2001 and 2002 that were used in this study included: an
encrypted identity number, age, gender, numbers and
types of encounters, category of caregiver and diagnoses.
Cost calculations
The Patient-level Clinical Costing method yields informa-
tion about health care costs on an individual level, and
was initially used within hospital care in Sweden. The first
application of this costing method in PHC was done at
Ödeshög [21][22]. Data on costs per patient in 2001 and
2002 from that study were used for the patients at
Ödeshög. In order to estimate individual patient costs at
Ryd, data from all patient contacts (i.e. both direct and
indirect contacts) during 2001 and 2002 were extracted
from the EPRs at Ryd, including an encrypted identifica-
tion number for each patient, the profession of the car-
egiver, contact date and type of contact (e.g. face-to-face
encounter, telephone, house call or contact through a
third party), and these contacts were priced according to
their resource consumption. This included costs for the
time consumed of all kinds of personnel, localities, com-
puter systems, and overhead costs, together with all kinds
of laboratory service, and x-ray, but not including costs for
other referrals or drugs.
The yearly cost per patient was subsequently calculated by
adding all the costs for all contacts in PHC for that patient
during each year.
All costs were calculated in Swedish crowns (SEK)
(exchange rate June 2001: 1 Euro = SEK 9.20).BMC Public Health 2006, 6:36 http://www.biomedcentral.com/1471-2458/6/36
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ACG grouping
Only patients with at least one registered IDC-10 code
during a calendar year were included in the ACG group-
ing, and consequently only these patients were included
in the creation and application of ACG weights. Data on
patients at both PHC centres with registered diagnoses
during 2001 and 2002 were extracted from the EPRs. The
patients were assigned to ACGs using version 6.0 of the
ACG software [23]. This is constructed to use the codes
from the International Classification of Diseases, Ninth
Revision (ICD-9), and the classification in use (ICD-10)
was therefore mapped to ICD-9 codes by use of cross-
mapping tables from the WHO [24].
Creating ACG weights
The data on individual patient costs from Ödeshög were
used to create the ACG weights. Patients with costs more
than three standard deviations above the mean were
excluded in order to prevent a few extremely costly
patients from producing a false high mean cost for some
ACGs. The calculation of weights was done by using each
individual patient's costs for 2001 and for 2002 at
Ödeshög, which were then applied to the categories of
patients in terms of ACGs. Cost data from both years were
used in order to get a sufficient number of individual
yearly costs in each ACG. Relative ACG weights were then
calculated and defined as the mean cost for each ACG
divided by the mean cost for all ACGs.
Application of ACG weights
The relative weights of ACGs (from Ödeshög) were
assigned to each patient at Ryd based on that patient's
individual ACG assignment. Patients at Ryd with costs
more than three standard deviations above the mean were
excluded. The usefulness of ACG in explaining individual
patient costs was explored in a concurrent model by com-
paring data from Ryd separately for 2001 and 2002.
The relative ACG weights applied (from Ödeshög, based
on both 2001 and 2002) were compared with ACG
weights from Ryd, from the USA (a database at Johns
Hopkins University) [23], and from Canada (two sites,
Manitoba and British Columbia) [3] in the concurrent
model.
The usefulness of ACG in estimating patient costs for indi-
viduals was explored in a prospective model by compar-
ing data from 2001 with costs from 2002 at Ryd.
Statistics
Spearman's correlation coefficient (Spearman's rho) was
used for bivariate correlation for each year between the
variables age, gender and ACG weights in a concurrent
model. Stepwise multiple linear regression analysis was
then used, for each year, to explore the variation of indi-
vidual patient costs with age, gender, and ACG weights as
the independent variables.
In order to estimate the predictive usefulness on an indi-
vidual level in a prospective model, another stepwise mul-
tiple linear regression analysis was performed with the
individual patient costs in 2002 as the dependent variable
and age, gender, ACG weights in 2001, and individual
patient costs in 2001 as the independent variables.
The statistical software SPSS® version 11.5 was used.
Results
The mean cost per patient at Ödeshög was higher com-
pared with Ryd both in 2001 and 2002 (Table 1). At both
PHC centres the variation in individual patient costs
within age groups was considerable in both years. The
mean cost for women was about 30% higher than for
men. The number of patients, both those with and those
without a registered diagnosis, increased substantially in
2002.
Data from Ödeshög were used for the creation of ACG
weights. Thus there were 3 073 patients diagnosed by a GP
in 2001, and 3 144 patients in 2002, who were grouped
by the ACG system (Table 1). These relative ACG weights
ranged from 0.3001 to 4.1798. Data from Ryd were used
for the evaluation of ACG weights. There were 4 478
patients diagnosed by a GP in 2001 and grouped by the
ACG system. A total of 5 163 patients had an encounter
with the PHC centre at Ryd during this year. The variation
in individual patient costs within each ACG was substan-
tial (Table 2). As can be seen in the table, the very high rel-
ative weights for ACG # 4420, a group of patients with a
constellation of 4–5 types of morbidities, correspond to
the very highest mean costs per patient.
Table 1: Characteristics of patients at Ryd and Ödeshög PHC 
centres
Ödeshög Ryd
2001 2002 2001 2002
Number of patients
- enrolled 5 600 5 600 9 000 9 000
- contacting the PHC 4 075 4 122 5 163 6 539
- diagnosed by a GP 3 073 3 144 4 478 5 358
Number of diagnoses/patient 2.07 2.04 2.28 2.17
Mean age 45.8 46.9 36.4 35.9
Proportion of females 54.2 53.3 52.1 57.9
Mean costs per patient (SEK)* 3 331 3 293 2 356 2 265
Mean ACG weight 1.0 ** 1.07 1.19
* Swedish Crowns
** 1.0 since the individual patients costs for the two years together 
were the base for the weightsBMC Public Health 2006, 6:36 http://www.biomedcentral.com/1471-2458/6/36
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The individual patient costs and other variables at Ryd
showed a correlation of 0.633 (Spearman's rho) for ACG
weights, 0.308 for age, and 0.119 for gender in 2001 in
the concurrent model. In 2002 the results were similar.
Age, gender and ACG weights (as independent variables
in a stepwise multiple regression analysis) together
explained 38.5% of the individual patient costs in 2001
(Table 3), and this figure was 34.3% in 2002. In 2001,
ACG weights explained 37.7% of the variance in the con-
current model, while age and gender added 0.8%. Age and
gender alone explained 11.4%. In 2002 the results were
similar.
Replacing the ACG weights from Ödeshög with relative
weights from other areas resulted in about the same or
lower adjusted R-square values. These weights yielded the
following values: 0.377 (Ryd), 0.203 (USA), 0.320 (Mani-
toba, Canada), and 0.337 (British Columbia, Canada).
The costs of individual patients in 2001 turned out to be
the most important factor, by 22.0%, for estimating the
individual patient costs at Ryd in 2002 in the prospective
model (Table 4). The ability of the ACG weights alone to
estimate patient costs next year was 14.3%. The gender
factor did not affect the result to any degree and thus has
been omitted in the table.
Discussion
In this study the ACG weights were found to be a major
factor in a concurrent model, explaining patient costs dur-
ing one and the same year. Age and gender explained
about 11% of the individual patient costs, and when the
ACG weights were added, the explanatory ability was
improved and reached 38.5%. The ACGs with more com-
plex constellations of types of morbidity were generally
more resource consuming, indicating the influence of
comorbidity. When estimating costs the next year in a pro-
spective model, the ACG weights constituted the second
most important factor, while the costs the preceding year
were the major factor.
Table 2: The most frequent ACGs, distribution of patients, mean and range for costs per patient in Swedish crowns (SEK) at Ryd PHC 
centre in 2001. (N = 4478)
ACG ACG Costs per patient (SEK)
Group Description N Mean Range
0300 Acute minor, age 6+ 646 1 048 90 – 15 755
4100 2–3 other ADG combinations, age >34 555 3 812 153 – 44 693
0500 Likely to recur without allergy 458 1 048 90 – 12 905
0400 Acute major 356 1 480 50 – 14 773
0900 Chronic medical, stable 307 1 542 90 – 19 271
2100 Acute minor & Likely to recur 174 2 120 90 – 13 455
1800 Acute minor & Acute major 160 2 540 530 – 27 116
2300 Acute minor & Chronic medical, stable 115 2 416 106 – 11 332
2800 Acut major & Likely to recur 103 2 613 220 – 34 406
0800 Chronic medical, unstable 102 2 630 90 – 16 034
1600 Preventive / Administrative 98 978 90 – 4 267
4420 4–5 ADG, 1 major, age >44 93 6 523 683 – 33 465
Total 3 167
ACG Relative weights
Group Ödeshög Ryd USA Manitoba British Columbia
0300 0.55 0.39 0.18 0.23 0.27
4100 1.33 1.47 1.11 0.97 0.79
0500 0.46 0.38 0.25 0.26 0.21
0400 0.61 0.56 0.42 0.35 0.27
0900 0.60 0.58 0.33 0.37 0.34
2100 0.95 0.81 0.43 0.51 0.56
1800 1.06 0.95 0.71 0.60 0.72
2300 1.02 0.95 0.53 0.60 0.63
2800 1.11 1.00 0.91 0.72 0.54
0800 0.96 0.98 1.02 0.59 0.49
1600 0.48 0.34 0.14 0.22 0.14
4420 2.06 2.56 2.76 1.85 1.53BMC Public Health 2006, 6:36 http://www.biomedcentral.com/1471-2458/6/36
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It can be argued that costs from year one should not be
used as a factor to estimate costs in year two in a prospec-
tive model, since most costs at a PHC centre are relatively
stable. In this case, though, we studied not only costs on
ACG group level, but also the yearly costs of individual
patients. Thus it is worthwhile to include prior costs as a
variable in the analysis in order to reflect the year to year
variability in the individual patient's costs, when evaluat-
ing the potential of the ACGs in the prospective model.
The results in this study were in accordance with findings
in a Canadian study based on physician claims, where age
and gender explained 9% of the variation in costs, a figure
that increased to 53% when Aggregated Diagnosis Groups
were added [3]. In a Spanish study in which prospective
registration of diagnoses that was independent of registra-
tion of other medical information, and in which the
number of GP consultations (without cost estimation)
was used as outcome measure, the corresponding figures
were 7% for age and gender and 50% when ACGs were
included [18]. The ability of the ACGs to estimate about
15% of individual patient costs in the following year in
our study was in line with a claims-based study in the USA
[15].
With respect to the cost calculations, the contact-based
analysis of individual patient costs can be considered suf-
ficiently detailed to provide a reliable distribution of costs
between patients. Registration of patient contacts in the
EPR was a prerequisite for enabling the caregiver to record
medical information, and consequently the drop-out rate
was low.
The original diagnoses were coded in ICD-10 and con-
verted to ICD-9-codes. The crossover mapping was
checked manually to ensure that it was as precise as possi-
ble. The fact that ACG grouping is not based on the
number of encounters with a specific diagnosis, but on
the mere appearance of a diagnosis (once or on several
occasions during a whole year), makes the ACG system
less sensitive to variations in the completeness of diagno-
sis recording. The effects of physician preference are fur-
ther reduced, since the ACG system categorises diagnoses
in only 32 types of morbidity (the ADGs).
In our study the ACG weighting appears to be sensitive to
the accuracy with which physicians enter diagnoses into
the EPRs. The coding situation in PHC in Sweden is
reported to be quite accurate, but there is still a need for
improved quality [25]. Due to the organisation of the
EPRs at Ryd, a more complete registration of diagnoses
was done there than at Ödeshög, resulting in a higher
mean ACG weight albeit lower mean patient costs.
To explain the influencing factors in the concurrent model
in more detail, it could be appropriate to analyse the case-
mix of patients at Ryd a bit further. As can be seen in Table
1, the mean ACG weight increased significantly from year
one to year two, as did the number of patients grouped,
although the mean costs per patient were lowered. Also,
the proportion of females was higher the second year
along with a decline in mean age. However, these factors
did not affect our results in the prospective model, as we
used the subset of patients being diagnosed both years as
the basis for the estimate.
Table 3: Multiple linear stepwise regression analysis with individual costs per patient in 2001 at Ryd PHC centre as dependent variable, 
concurrent model
Adjusted R2 = 0.385 95% CI of b-coefficient
Independent variables Unstandardised b-
coefficient
Lower Upper P-value
ACG weights 1 974 1 886 2 062 <0.001
Age 8 6 11 <0.001
Gender -215 -315 -116 <0.001
Table 4: Multiple linear stepwise regression analysis with individual costs per patient in 2002 at Ryd PHC centre as dependent variable, 
prospective model
Adjusted R2 = 0.267 95% CI of b-coefficient
Independent variables 2001 Unstandardised b-
coefficient
Lower Upper P-value
Costs 0.28 0.25 0.31 <0.001
ACG weights 599 455 743 <0.001
A g e 1 61 32 0 < 0 . 0 0 1BMC Public Health 2006, 6:36 http://www.biomedcentral.com/1471-2458/6/36
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The creation of ACG weights was limited by the fact that
not all patients (i.e. only those with at least one diagnosis
per year) were included. However, since the costs of all
patients without any diagnosis constituted no more than
2.5% of the total, this limitation probably affects our
results to only a minor degree. A further limitation of the
ACG weights was that the population of Ödeshög was
small. This was mitigated to some extent by aggregating
data from two consecutive years. Nevertheless, there were
still some ACGs with only a few patients, making these
weights uncertain. Constructing weights for a larger pop-
ulation might have resulted in greater explanatory ability.
However, weights provided by the ACG software [23],
based on a reference population of 2 000000 subjects in
the USA, gave an adjusted R-square as low as 0.20 in our
population, compared to Canadian weights from Mani-
toba and British Columbia with an adjusted R-square of
0.32 and 0.34, respectively. Hence, data from the Swedish
PHC centre in Ödeshög were found to yield more useful
relative weights for a Swedish PHC setting compared to
weights based on statistically well-founded data from the
USA and Canada.
When exploring the predictive usefulness, the individual-
based approach is limited by the fact that it is based on a
sub-population of individuals (i.e. only patients who are
included both years), which is not fully representative for
the whole population. However, our figures give an idea
of the usefulness of the ACG weights in estimating indi-
vidual patient costs, as well as an idea of the continuity of
individual patient costs.
Efforts to construct a more comprehensive database on
costs per patient in PHC are ongoing, based on the same
population as reported in the adjacent article (with PHC
data for three years from a Swedish county) in this issue of
BMC Public Health. That analysis might lead to a higher
degree of certainty when using relative ACG weights. The
possibility of integrating data on drug prescriptions, as is
indicated in a new version of the ACG grouping software,
might improve the usefulness of the system in concurrent
as well as prospective models.
It would have been advantageous to test the significance
of a socio-economic variable, such as the Care Need
Index, in explaining and estimating patient costs [26].
However, the CNI was not applicable in our study because
of the small number of individuals at Ryd, and because of
the skewed distribution of CNI scores, since 85% of the
patients were found in only five indexed areas. Individual
socio-economic data were not available in our study, but
will probably be needed in order to explain and estimate
individual patient costs more accurately. Further, there is
need for more research and development in this area, also
integrating other variables such as functional and self-per-
ceived health status measures.
In the future, measures will be required to reduce the var-
iation and enhance the quality of diagnostic coding in
PHC. However, it is unrealistic to expect that this problem
can be totally eliminated, as the criteria used for diagnos-
tic labelling by different physicians have been shown to
vary [27]. Thus, introduction of methods that might com-
pensate for variations in the completeness of physicians'
registration of diagnoses could increase the usefulness of
the ACG system.
Conclusion
The comorbidity, expressed by the individual constella-
tion of morbidities in the ACG system, was associated
with a large proportion of the variation in PHC costs. Age
and gender could explain individual patient costs to a
minor degree. Accordingly, the ACG system has the poten-
tial to be a useful instrument for describing and explain-
ing concurrent resource consumption in PHC, even on the
PHC centre level, as well as for estimating future costs for
health care in a prospective model. As the ACG system
appears to be sensitive regarding the accuracy with which
physicians register diagnoses, measures will be required to
reduce this variation and enhance the quality of diagnos-
tic coding in PHC. Individual socio-economic data, as
well as other health related measures, will probably be
needed in future studies in order to reinforce the explana-
tion and estimation of individual patient costs.
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